Moreover, incidence of mutation in p53 gene was related with the lower rate of survival, and the expression of HER-2/neu was associated with higher probability of developing the intestinal type of stomach adenocarcinoma and ulcerative gross feature. The gene discussed is ERBB2; the disease is gastric adenocarcinoma.